no_english_version

no_arabic_version

Este material no está traducido en su totalidad. Mayo Clinic se esfuerza en publicar nuevos materiales traducidos con frecuencia.

Ensayos clínicos

Lymphoma of the gastrointestinal tract

Displaying 1 study

Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma Rochester, MN

RATIONALE: Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Lenalidomide may stop the growth of cancer cells by blocking blood flow to the cancer. Giving everolimus together with lenalidomide may be an effective treatment for lymphoma.

PURPOSE: This phase I/II trial is studying the side effects and best dose of giving everolimus and lenalidomide together and to see how well they work in treating patients with relapsed or refractory non-Hodgkin or Hodgkin lymphoma.